Actively Recruiting
Evaluating Safety and Effectiveness of Cold Atmospheric Plasma Devices for Moderate-to-Severe Acne Vulgaris in Adults
Led by Shenyang Medical College · Updated on 2026-01-02
220
Participants Needed
1
Research Sites
20 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of cold atmospheric plasma CAP therapy for people with moderate-to-severe acne vulgaris, a common chronic skin condition with complex causes and limited treatment options. This condition involves inflammation and overgrowth of certain bacteria, leading to various skin lesions. Current treatments can have side effects or resistance issues, so this study aims to test two new CAP devices designed to offer antimicrobial and skin-healing benefits as an innovative alternative. Participants will be randomly assigned to either a CAP treatment group or a placebo group. Those in the CAP group will receive up to six weekly sessions of CAP therapy using two specially designed devices to target different facial areas, with treatment stopping early if acne clears completely. The placebo group will receive sham CAP therapy that simulates the treatment without producing plasma. Both groups will also receive standard care based on established acne guidelines. During the study, participants will be monitored for changes in acne lesion clearance rates over six weeks, quality of life improvements through questionnaires, and time to achieve significant lesion reduction. Researchers will assess safety and treatment effects through clinical evaluations. The study will last six weeks after randomization, providing detailed follow-up and comparison between CAP therapy and placebo in managing moderate-to-severe acne vulgaris.
CONDITIONS
Brief Title
Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study
Research Team
Y
Yun-En Liu, MD
L
Lin Tao, MM
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here